Walgreens has agreed to pay up to $350 million to settle allegations that it knowingly filled millions of unlawful opioid and other controlled-substance prescriptions and submitted false claims to federal health programs, the Justice Department announced April 21.
The settlement resolves claims that Walgreens violated both the Controlled Substances Act (CSA) and the False Claims Act (FCA) from 2012 through 2023.
